B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Fexagratinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fexagratinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

erdafitinib
5 shared targets
ly
5 shared targets
futibatinib
5 shared targets
pemigatinib
4 shared targets
fisogatinib
4 shared targets
h3b
4 shared targets
pd
5 shared targets
fgfr
5 shared targets
lucitanib
5 shared targets
lenvatinib
6 shared targets
Loading evidence profile...

This evidence profile for Fexagratinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.